Skip to main content
. 2020 Aug 10;31(6):e83. doi: 10.3802/jgo.2020.31.e83

Fig. 2. Flow chart for describing patient distribution in the present study.

Fig. 2

BA, benign stand-alone evidence; BP, benign supporting evidence; BS, benign strong evidence; PM, pathogenic moderate evidence; PP, pathogenic supporting evidence; PS, pathogenic strong evidence; PV, pathogenic variants evidence; PVS, pathogenic very strong evidence; VUS, variants of unknown significance.